Diagnostics M&A Deals Skyrocket in 2021 as Companies Have COVID-19 Cash to Burn


Published in 360Dx

Author: Kelsy Ketchum


As many diagnostics companies continued to benefit from high volumes of COVID-19testing, cash burned a hole in the pockets of many in the industry, and major players and smaller newbies alike picked up new businesses. 

View full article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278